Literature DB >> 11179963

Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.

N Rochel1, G Tocchini-Valentini, P F Egea, K Juntunen, J M Garnier, P Vihko, D Moras.   

Abstract

Vitamin D nuclear receptor mediates the genomic actions of the active form of vitamin D, 1,25(OH)2D3. This hormone is involved in calcium and phosphate metabolism and cell differentiation. Compared to other nuclear receptors, VDR presents a large insertion region at the N-terminal part of the ligand binding domain between helices H1 and H3, encoded by an additional exon. This region is poorly conserved in VDR in different species and is not well ordered as observed by secondary structure prediction. We engineered a VDR ligand binding domain mutant by removing this insertion region. Here we report its biochemical and biophysical characterization. The mutant protein exhibits the same ligand binding, dimerization with retinoid X receptor and transactivation properties as the wild-type VDR, suggesting that the insertion region does not affect these main functions. Solution studies by small angle X-ray scattering shows that the conformation in solution of the VDR mutant is similar to that observed in the crystal and that the insertion region in the VDR wild-type is not well ordered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179963     DOI: 10.1046/j.1432-1327.2001.01953.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies.

Authors:  Jinge Zhu; Hongyu Rao; Marco Tonelli; William M Westler; Kiran K Singarapu; John L Markley; Hector F DeLuca; Fariba M Assadi-Porter
Journal:  Protein Expr Purif       Date:  2012-06-29       Impact factor: 1.650

2.  Inactivation of the human vitamin D receptor by caspase-3.

Authors:  Peter J Malloy; David Feldman
Journal:  Endocrinology       Date:  2008-10-01       Impact factor: 4.736

3.  Alternatively spliced isoforms of the human constitutive androstane receptor.

Authors:  Scott S Auerbach; Richard Ramsden; Matthew A Stoner; Christophe Verlinde; Christopher Hassett; Curtis J Omiecinski
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

4.  The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation.

Authors:  Yvonne S Lin; Kazuto Yasuda; Mahfoud Assem; Cynthia Cline; Joe Barber; Chia-Wei Li; Vladyslav Kholodovych; Ni Ai; J Don Chen; William J Welsh; Sean Ekins; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

5.  The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species.

Authors:  Matthew D Krasowski; Ni Ai; Lee R Hagey; Erin M Kollitz; Seth W Kullman; Erica J Reschly; Sean Ekins
Journal:  BMC Biochem       Date:  2011-02-03       Impact factor: 4.059

6.  1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.

Authors:  Ferdinand Molnár; Rita Sigüeiro; Yoshiteru Sato; Clarisse Araujo; Inge Schuster; Pierre Antony; Jean Peluso; Christian Muller; Antonio Mouriño; Dino Moras; Natacha Rochel
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 7.  Vitamin D status and risk for malignant cutaneous melanoma: recent advances.

Authors:  Maria N Ombra; Panagiotis Paliogiannis; Valentina Doneddu; Maria C Sini; Maria Colombino; Carla Rozzo; Ignazio Stanganelli; Francesco Tanda; Antonio Cossu; Giuseppe Palmieri
Journal:  Eur J Cancer Prev       Date:  2017-11       Impact factor: 2.497

Review 8.  Vitamin D and Its Receptor from a Structural Perspective.

Authors:  Natacha Rochel
Journal:  Nutrients       Date:  2022-07-12       Impact factor: 6.706

Review 9.  Structural considerations of vitamin D signaling.

Authors:  Ferdinand Molnár
Journal:  Front Physiol       Date:  2014-06-06       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.